Literature DB >> 6298638

Characterization of a human colon/lung carcinoma oncogene.

M S McCoy, J J Toole, J M Cunningham, E H Chang, D R Lowy, R A Weinberg.   

Abstract

DNA sequences capable of inducing oncogenic transformation of NIH3T3 mouse cells are found in a number of human tumour cell lines. When DNAs of these cell lines are applied to monolayer cultures of the mouse fibroblasts, foci of transformed cells are observed 2-3 weeks later. DNA from cells of such primary foci can be used in turn to induce foci in a second cycle of gene transfer. The human DNA sequences responsible for transformation have been called oncogenes, the best characterized of which is closely related to the Harvey murine sarcoma virus oncogene. Here we present a characterization of an oncogene which we found originally to be present in DNA of the SW480 colon carcinoma cell line. We indicate its structural outlines and demonstrate, in extension of reported results, its presence in an activated form in the genome of several types of human tumour cell lines as well as in biopsy tissue from an adenocarcinoma of the large bowel. We identify this tumour oncogene with c-Ki-ras2, one of two known members of the Kirsten ras family of human proto-oncogenes, extending a series of recent reports which have demonstrated homologies between human oncogenes and those of Harvey and Kirsten murine sarcoma viruses. The c-Ki-ras2 oncogene of several tumour cell lines is shown to be amplified.

Entities:  

Mesh:

Year:  1983        PMID: 6298638     DOI: 10.1038/302079a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  67 in total

1.  Activating mutations and/or expression levels of tyrosine kinase receptors GRB7, RAS, and BRAF in testicular germ cell tumors.

Authors:  Alan McIntyre; Brenda Summersgill; Hayley E Spendlove; Robert Huddart; Richard Houlston; Janet Shipley
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

Review 2.  Mutation-associated fusion cancer genes in solid tumors.

Authors:  Frederic J Kaye
Journal:  Mol Cancer Ther       Date:  2009-06-09       Impact factor: 6.261

3.  Sample type bias in the analysis of cancer genomes.

Authors:  David A Solomon; Jung-Sik Kim; Habtom W Ressom; Zita Sibenaller; Timothy Ryken; Walter Jean; Darell Bigner; Hai Yan; Todd Waldman
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

Review 4.  Human oncogenes.

Authors:  K Willecke; R Schäfer
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

5.  Isolation and characterization of a stage-specific transforming gene, Tlym-I, from T-cell lymphomas.

Authors:  M A Lane; A Sainten; K M Doherty; G M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  Regional localization of two human cellular Kirsten ras genes on chromosomes 6 and 12.

Authors:  A Y Sakaguchi; B U Zabel; K H Grzeschik; M L Law; R W Ellis; E M Scolnick; S L Naylor
Journal:  Mol Cell Biol       Date:  1984-05       Impact factor: 4.272

7.  Oncogene amplification during tumorigenesis of established rat fibroblasts reversibly transformed by activated human ras oncogenes.

Authors:  E Winter; M Perucho
Journal:  Mol Cell Biol       Date:  1986-07       Impact factor: 4.272

8.  Comparative study of the expression of Rb and p53 genes in human colorectal cancers, colon carcinoma cell lines and synchronized human fibroblasts.

Authors:  M L Gope; M Chun; R Gope
Journal:  Mol Cell Biochem       Date:  1991-09-18       Impact factor: 3.396

9.  Regional chromosomal localization of N-ras, K-ras-1, K-ras-2 and myb oncogenes in human cells.

Authors:  O W McBride; D C Swan; S R Tronick; R Gol; D Klimanis; D E Moore; S A Aaronson
Journal:  Nucleic Acids Res       Date:  1983-12-10       Impact factor: 16.971

10.  A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient.

Authors:  M H Kraus; Y Yuasa; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.